New nanomaterials to understand and cure the human brain: from science to medicine

Event Details

  • Date:
  • Venue: ICN2 - Seminar Hall
  • Address: Edifici ICN2, Universitat Autònoma de Barcelona, 08193 Bellaterra
  • Categories:


By Dr Carolina Aguilar, CEO of the ICN2 spinoff InBrain Neuroelectronics


Abstract: Dr. Carolina Aguilar is the CEO of the ICN2 spinoff InBrain Neuroelectronics, a company making fast advances in the field of therapies for neural diseases such as Parkinson´s and Epilepsy. She will share with us her transition from science to technology, industry and lately venturing; and her plans to contribute to the medicine of the future. This is a unique opportunity to hear a world leader in medical technology tell her story, recall her collaboration with ICN2 researchers and answer questions on transitioning form science to industry.

Biography: Carolina Aguilar graduated with a PhD in Pharmacy from the Universidad Complutense de Madrid, and received post-graduate degree for Wharton School of Business, Virginia Polytechnic University, MIT´s Sloan School of Business and IESE. She was a Director for Medtronic, one of the largest conglomerates in medical technologies. Since 2019, she is the CEO of the ICN2 spinoff InBrain Neuroelectronics (

Hosted by Pablo José Pomposiello, Head of ICN2 Business and Innovation Department